Oliver P. Peoples - Mar 1, 2022 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
Pres and CEO, Director
Signature
/s/ Megan N. Gates, attorney-in-fact
Stock symbol
YTEN
Transactions as of
Mar 1, 2022
Transactions value $
-$7,765
Form type
4
Date filed
3/3/2022, 06:59 PM
Previous filing
Feb 14, 2022
Next filing
Aug 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YTEN Common Stock Tax liability -$7.76K -1.83K -3.53% $4.25* 49.9K Mar 1, 2022 Direct F1
holding YTEN Common Stock 4.99K Mar 1, 2022 By 40l(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 3/1/2021.
F2 Shares acquired as Issuer matching contributions under the Yieldl0 Bioscience, Inc. 401(k) Plan.